Navigation Links
eDiets.com(R) Announces Q3 2008 Results
Date:11/13/2008

Interest income, net 63 (63) 11 (148)

Interest expense on

secured notes 542 126 1,382 126

Amortization of secured

notes 321 62 836 62

Income tax provision 19 55 20 197

Depreciation 437 312 1,127 759

Amortization of

intangibles 176 303 705 908

Stock-based

compensation 288 463 1,046 1,167

Loss on disposition of

fixed assets - 154 1 176

Bad debt expense (7) (1) 82 11

Severance charges 4 (12) 39 74

Adjusted EBITDA $(1,356) $(1,096) $(6,204) $(1,865)

Safe Harbor Statement

Statements which are not historical in nature are forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties which could cause the actual results, performance or achievements to be materially different from those which may be expressed or implied by such statements. These risks and uncertainties include, among others, that we will not be able to obtain sufficient and/or acceptable outside financing (when and if required); changes in general economic and business conditions; changes in product acceptance by consumers; a decline in the effectiveness of sales and marketing efforts; loss of market share and pressure on prices resulting from competition; significant investments in our technology platform, marketing plans, and product development to remain competitive with other online providers of healthy living and weight loss plans, many of which may be found to offer superior and more varied features than our
'/>"/>

SOURCE eDiets.com, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. eDiets.com(R) to Report Third Quarter 2008 Results on Thursday, November 13, 2008
2. eDiets.com(R) Announces Q2 2008 Results
3. eDiets.com(R) Appoints New Chief Information Officer Laura Klein
4. eDiets.com(R) Announces Q1 2008 Results
5. eDiets.com(R) to Report First Quarter 2008 Results on Tuesday, May 13, 2008
6. eDiets.com(R) Announces Q4 and Year End 2007 Results
7. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
8. Pharmos Corporation Announces Receipt of Nasdaq Noncompliance Letter
9. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
10. Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer
11. In a Down Economy, Womens Health Company Announces Growth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...HINGTON, Nov. 9 The Churchill Ce...ward For Leadership to J.W. "Bill" Marriott for hi...gh progressive free market practices and fostering...Mr. Marriott will receive his award at a ceremony ...on D.C. Four Seasons Hotel. ,, "This is a test...
(Date:11/9/2009)... ANGELES, Nov. 9 Tracy Anderson, t...nd Kate Hudson, will be hosting two events at her ...Finally sharing her long awaited Nutritional Meal ...ng her TA Baby Food Cleanse and Lifestyle Menu. S...porates her entire method of cardio and muscle str...
(Date:11/9/2009)...y be left atrial enlargement, study finds , ...s a major risk factor for left atrial enlargement,...stroke and death, a new study shows. , Atrial f...(an irregular heart rhythm or heartbeat). , Re...ed 25 to 74, in Germany who were followed for 10 y...
(Date:11/9/2009)... Studying Genetic Variance Across ... of Genes , (Vocus) Novem...tries can be extraordinarily valuable when analyzi...-center genetics study that scanned the genomes ...regional differences, Drs. Chao Tian and Michael F...
(Date:11/9/2009)...ly due to fact that both eye conditions are age-re...9 (HealthDay News) -- Cataract surgery doesn,t app...r degeneration (AMD), according to a new study tha... vision loss worsens the other. , "Because both...uals with cataract also have AMD," wrote Li Ming D...
Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week 2Health News:News from the November/December Issue of Molecular Medicine 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2
...eam of doctors from different specialties, recentl...roach can benefit cancer patients. Dr. Peter Costa... found a rare and often fatal tumor in Angela Carr...gnosed in 2002. This type of cancer makes up about...
...ry year, more than 5 million people go to the Emer... for 20 to 30 minutes. Most receive an ECG and oth...a heart attack or other serious heart problems. Ho...in. Researchers suggest// that about 2 percent of ...
...riasis patients who have been long-awaiting new op...ood and Drug Administration's approval of the new ...immune cells to control hard-to-treat psoriasis. P...that are currently available for psoriasis range f...
...ple have been concerned, for many decades now, abo...e smile. But tooth discolouration is a persistent ...les in food and drink. Back in the Middle Ages, pe...red many easy and ingenuous ways of maintaining te...
...ecent study has has shown that oxygen, apart from ... Prior studies have shown that oxygen plays an imp.... In fact, studies have shown treatment in a hyper...ity. The researchers of the new have now suggested...
...nking milk has always been associated with good he...o drink milk to grow up healthy. However, a recent... well established fact(or is it still?). A study i...ein and the national rate of heart disease and ins...
Other Medicine News:Health News:New and unique treatment for Psoriasis patients 2
(Date:11/9/2009)..., AUSTIN, Texas, Nov. 9 Celli...rs, is collaborating with Tissue Genesis, Inc. to ... derived adult stem cells. SpineSmith acquired th...se (fat) tissue derived stem cell technology in No...this new exclusive agreement allows Celling Techno...
(Date:11/9/2009)..., ST. LOUIS, Nov. 9, 2009 /PRNewswire-FirstCa...nc (NYSE: PFE ) today announced that they have en...izer,s Chesterfield Village Research Center locate...eement, Monsanto will acquire the property from Pf...izer will continue to have operations at Chesterfi...
(Date:11/9/2009)..., PISCATAWAY, N.J., Nov. 9 /PRNewswire-FirstC...ard: MLSS), the recognized leader in computer-cont...t it will be showcasing its patented, award-winnin...ystem) at the Madow Group,s 15th year of TBSE tit... place at the Las Vegas Hilton. ,, The STA S...
Breaking Medicine Technology:Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3Milestone Scientific to Exhibit at the 15th Anniversary of TBSE (The Best Seminar Ever) in Las Vegas 2Hard to Treat Diseases Inc 28HTDS 29 Reports on Ribavirin Research as Potential Treatment for MS 52558 1Hard to Treat Diseases Inc 28HTDS 29 Reports on Ribavirin Research as Potential Treatment for MS 52558 2Hard to Treat Diseases Inc 28HTDS 29 Reports on Ribavirin Research as Potential Treatment for MS 52558 3Video of EpiDerm Skin Irritation Test 28SIT 29 Method Now Available 13170 1Video of EpiDerm Skin Irritation Test 28SIT 29 Method Now Available 13170 2Twinlabs 28R 29 Mobile Beach Bash Heats Up After a Successful Kick Off of the 2009 RateYourAbs com Contest 52549 1Twinlabs 28R 29 Mobile Beach Bash Heats Up After a Successful Kick Off of the 2009 RateYourAbs com Contest 52549 2
....Y.--(BUSINESS WIRE)--Jun 18, 2007 - Advanced Vira...iopharmaceutical,company, announced today that pre...ological study show topical treatment with AVR118,...ammation and,redness associated with surgical inci...open label dermatological study is evaluating the,...
...an 70 abstracts highlight VELCADE efficacy in broa...-, CAMBRIDGE, Mass., June 19, 2007 /PRNewswire-Fir...announced that data for,VELCADE, the market leadin...or patients with previously treated multiple myelo...ional Myeloma,Workshop (IMW) in Kos, Greece, June ...
Other Medicine Technology:Advanced Viral Research Corp. Announces Positive Preliminary,Findings from Ongoing Phase II Dermatological Study 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8
DeepLight Glaucoma Treatment System
Verity Adx Pacemaker
Regency Pacemaker
Identity® Adx Pacemaker
Medicine Products: